Carbonic Anhydrase IX

2

Review clinical trials related to Carbonic Anhydrase IX. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer Patients

To evaluate the efficacy of targeted CAIX-specific probe PET imaging in the diagnosis and staging of kidney cancer, as well as to assess its role in prognosis prediction and treatment evaluation for kidney cancer.

Participants needed: 113
Trial details
Age: 18-74Biological sex: AllType: ObservationalSponsor: The First Affiliated Hospital of Xiamen UniversityUpdated: May 29, 2025Locations: 1
Eligibility criteria

Voluntary participation with the patient or their legal representative able to s... [+7]

Pregnant or breastfeeding patients (all women of childbearing age must undergo p... [+4]

Status: Recruiting

68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma

The goal of this clinical trial is to evaluate the diagnostic value of CAIX protein specific probe 68Ga-C1 in PET/CT imaging in clear cell renal cell carcinoma patients. It will also learn about the safety, tolerability and radiation dosimetry of 68Ga-C1. Researchers will compare the diagnostic value of 68Ga-C1 PET/CT and 18F-FDG PET/CT in Chinese patients with indeterminate renal masses or confirmed clear cell renal cell carcinoma.

Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Peking University First HospitalUpdated: Nov 7, 2024Locations: 1
Eligibility criteria

Signed written informed consent; [+3]

Renal mass is known to be a metastasis of another primary tumor; [+6]